Access Medical Labs offers the CA 15-3 test as a single-biomarker lab test, which means that it focuses specifically on measuring the levels of CA 15-3 in the blood. This test can be ordered by healthcare providers to aid in the management of breast cancer patients.
CA 15-3 is a tumor marker that is commonly used in the monitoring of breast cancer. It is a protein that is produced by cancer cells, and elevated levels of CA 15-3 in the blood can determine the progression and effectiveness of treatment of the disease.
The CA 15-3 test is typically used in conjunction with other diagnostic tests and imaging techniques to provide a comprehensive assessment of a patient's breast cancer status. It is particularly useful in monitoring the effectiveness of treatment and detecting any recurrence of the disease.
CA 15-3, also known as cancer antigen 15-3, is a protein that is often used as a tumor marker in monitoring breast cancer. It is a glycoprotein that is produced by breast cancer cells and shed into the bloodstream. CA 15-3 levels can be measured through a blood test.
Elevated levels of CA 15-3 may indicate the presence of breast cancer, but it is important to note that this marker is not specific to breast cancer and can also be elevated in other conditions, such as ovarian, lung, and liver cancers. CA 15-3 is primarily used in conjunction with other diagnostic tests and imaging techniques to assess the progression of breast cancer, monitor treatment effectiveness, and detect any recurrence of the disease.
CA 15-3 is a tumor marker primarily used in the management of breast cancer. It is not typically used as a screening test but rather as a monitoring tool for patients with known breast cancer. CA 15-3 levels can be elevated in patients with advanced or metastatic breast cancer, and monitoring its levels over time can help assess response to treatment or detect disease recurrence.
Ideal candidates for CA 15-3 testing include:
Patients with a confirmed diagnosis of breast cancer: CA 15-3 testing can be used to monitor the progression of the disease, assess treatment response, and detect recurrence.
Patients with metastatic breast cancer: CA 15-3 levels can be particularly useful in monitoring the response to treatment and detecting disease progression in patients with metastatic breast cancer.
Patients with suspected recurrence: If a patient previously treated for breast cancer shows signs or symptoms suggestive of recurrence, CA 15-3 testing can be performed to help confirm the presence of recurrent disease.
It' is important to note that CA 15-3 is not specific to breast cancer and can be elevated in other conditions such as liver disease, lung cancer, ovarian cancer, and benign breast conditions. Therefore, it should be interpreted in conjunction with other clinical findings and imaging studies. The decision to test for CA 15-3 should be made in consultation with a healthcare provider familiar with the patient's medical history and individual circumstances.
A high CA 15-3 level refers to an elevated level of a specific biomarker called CA 15-3 in the blood. CA 15-3 is a protein that is produced by certain cells in the body, including breast cancer cells. It is commonly used as a tumor marker for breast cancer, although it can also be elevated in other conditions.
When a person has a high CA 15-3 level, it suggests the possibility of breast cancer, particularly in individuals who have been previously diagnosed with the disease. However, it is important to note that CA 15-3 is not a definitive diagnostic tool for breast cancer and cannot be used alone to confirm or rule out the presence of cancer.
There are several factors that can contribute to an elevated CA 15-3 level, including the size and stage of the tumor, the presence of metastasis (spread of cancer to other parts of the body), and the effectiveness of treatment. Other non-cancerous conditions, such as benign breast conditions, liver disease, and lung disease, can also cause an increase in CA 15-3 levels.
If a high CA 15-3 level is detected, further diagnostic tests, such as imaging studies (mammogram, ultrasound, MRI) and biopsies, may be recommended to determine the cause and to confirm or exclude the presence of breast cancer. It is important to consult with a healthcare professional who can interpret the CA 15-3 results in the context of the individual's medical history and other clinical findings.
A low CA 15-3 level refers to a lower than normal concentration of CA 15-3 in the blood. CA 15-3 is a tumor marker that is often used to monitor breast cancer progression and response to treatment.
In healthy individuals, CA 15-3 levels are typically low or undetectable. However, elevated levels of CA 15-3 can be found in the blood of some individuals with breast cancer. The level of CA 15-3 can indicate the presence and extent of the disease, as well as the response to treatment.
A low CA 15-3 level may have several implications:
Early-stage breast cancer: In the early stages of breast cancer, CA 15-3 levels may still be within the normal range or only slightly elevated. Therefore, a low CA 15-3 level could suggest that the cancer is in an early stage or has not yet spread significantly.
Effective treatment: If a person with breast cancer is undergoing treatment, a low CA 15-3 level may indicate that the treatment is effective in reducing tumor burden. This can be a positive sign that the therapy is working.
It is crucial to interpret CA 15-3 levels in the context of other clinical information and imaging studies. A single lab test result should not be used in isolation to make a diagnosis or treatment decision. Consulting with a healthcare provider, preferably an oncologist, is essential for proper evaluation and interpretation of CA 15-3 levels.
This is a single-marker test measuring CA 15-3. CA 15-3 may be useful in monitoring response to therapy in patients with metastatic breast cancer.
.svg){kind=small}
.svg){kind=small}
On December 11th, join Dr. Terry Wahls in a 
